China Resources Pharmaceutical Group Limited (3320.HK) HKSE
4.80
+0.03(+0.63%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.80
+0.03(+0.63%)
Currency In HKD
| Market Cap | 27.98B |
| Enterprise Value | 102.24B |
| P/E Ratio | 6.75 |
| PEG Ratio | 0.27 |
| Price/Sales Ratio | 0.1 |
| Price/Book Ratio | 0.53 |
| Enterprise/Revenue | 0.35 |
| Enterprise/EBITDA | 5.95 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.02 |
| Operating Margin | 0.05 |
| Return On Assets | 0.01 |
| Return On Equity | 0.08 |
| Revenue | 300.01B |
| Revenue/Share | 47.41 |
| Gross Profit | 49.53B |
| EBITDA | 17.7B |
| Net Income | 4.5B |
| Diluted EPS | 0.72 |
| Total Cash | 58.73B |
| Total Cash/Share | 9.35 |
| Total Debt | 104.87B |
| Total Debt/Equity | 1.83 |
| Current Ratio | 1.42 |
| Book Value Per Share | 20.83 |
| 52-Week Change | -5.14 |
| 52-Week High | 6.53 |
| 52-Week Low | 4.34 |
| Moving Average 50 Days | 5.45 |
| Moving Average 200 Days | 4.92 |
| Average Volume | 19.78M |
| Shares Outstanding | 6.28B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.13 |
| Trailing Annual Dividend Yield | 2.81 |
| Payout Ratio | 0.17 |
| Last Split Factor | N/A |
| Last Split Date | N/A |